Skip to Content

Press Releases

Press Releases

Nov 05 2020
Intec Pharma Reports Third Quarter 2020 Financial Results and Provides Corporate Update
JERUSALEM , Nov. 5, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the third quarter ended September 30, 2020 and provides a corporate update.  "We maintain our focus on executing strategic partnerships and collaborations.
Oct 29 2020
Intec Pharma Announces 1-for-20 Reverse Share Split
JERUSALEM , Oct. 29, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces a 1-for-20 reverse share split of its outstanding ordinary shares. The reverse share split is scheduled to become effective after trading closes on October 29, 2020 , and the
Oct 08 2020
Intec Pharma Announces New Research Collaboration Agreement with MSD
JERUSALEM , Oct. 8, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces it has entered into a new research collaboration agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth, NJ , USA. Details of the agreement are confidential.
Sep 14 2020
Intec Pharma to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
JERUSALEM , Sept. 14, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will present at the virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Date:
Sep 08 2020
Intec Pharma to Present at H.C. Wainwright 22nd Annual Global Investment Conference
JERUSALEM , Sept. 8, 2020 /PRNewswire/ --   Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will present at the virtual H.C. Wainwright 22 nd Annual Global Investment Conference . H.C. Wainwright 22 nd Annual Global Investment Conference Date:
Aug 07 2020
Intec Pharma Announces Pricing of $4.9 Million Registered Direct Offering
JERUSALEM , Aug. 07, 2020 (GLOBE NEWSWIRE) -- Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”), today announced that it has entered into a definitive agreement with Aspire Capital Fund (“Aspire”) for the purchase and sale, in a registered direct offering, of 7,125,000 of the Company’s
Aug 05 2020
Intec Pharma Reports Second Quarter 2020 Financial Results and Provides Corporate Update
JERUSALEM , Aug. 5, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the second quarter ended June 30, 2020 and provides a corporate update.  "We have worked diligently over the past quarter to address the challenges of an
May 28 2020
Intec Pharma to Present at Jefferies Virtual Healthcare Conference
JERUSALEM , May 28, 2020 /PRNewswire/ --  Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will present at the Jefferies Virtual Healthcare Conference . Jefferies Virtual Healthcare Conference Date: June 2 – June 4, 2020 Company Presentation:
May 11 2020
Intec Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update
JERUSALEM , May 11, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the first quarter ended March 31, 2020 and provides a corporate update.  Highlights from the Quarter and Recent Weeks Announced that the Accordion Pill (AP)
May 04 2020
Intec Pharma Announces $5.0 Million Registered Direct Offering
JERUSALEM , May 04, 2020 (GLOBE NEWSWIRE) -- Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”), today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 16,291,952 of the Company’s ordinary shares, at a
Displaying 1 - 10 of 116